Humalog Before Lunch Provides Later Benefits


By: Jan Chait

A recent study by French researchers demonstrated that taking an injection of Humalog (insulin lispro) before lunch can lower dinnertime blood-glucose levels in children and adolescents with type 1 diabetes. Boys in particular also saw improved overall blood-glucose control after adding the lunchtime Humalog.

Researchers randomly assigned 16 boys and 27 girls with an average age of 12.4 years to one of two groups: the first added an injection of Humalog at lunchtime and the second did not. Both groups ate identical meals for two months.

For those who took the lunchtime Humalog injection, the number of days on which their before-dinner blood glucose was greater than 180 was reduced by half, compared to those who omitted the injection. A1Cs also decreased slightly overall and were lowered significantly for boys who took the lunchtime injection, compared to boys who did not. The study found no significant difference in frequency of hypoglycemia or weight change between the two groups.

While the researchers report that the children were satisfied with the improved blood-glucose control, the number who continued to follow the protocol decreased during the subsequent six months.

—Diabetic Medicine, December 2002



Diabetes Health Medical Disclaimer
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.